Kircali, E. Et Al. 2021. Impact of Peritransplant Metronidazole Use on Acute Graft Versus Host Disease in Allogeneic Hematopoietic Transplant Patients. Transplantation and Cellular Therapy , vol.27, no.3 , 271.

Kircali, E., Seval, G. C., Bozdag, S. C., Yuksel, M. K., Topcuoglu, P., Arslan, O., ... Ozcan, M.(2021). Impact of Peritransplant Metronidazole Use on Acute Graft Versus Host Disease in Allogeneic Hematopoietic Transplant Patients. Transplantation and Cellular Therapy , vol.27, no.3, 271.

Kircali, Ekin Et Al. "Impact of Peritransplant Metronidazole Use on Acute Graft Versus Host Disease in Allogeneic Hematopoietic Transplant Patients," Transplantation and Cellular Therapy , vol.27, no.3, 271, 2021

Kircali, Ekin Et Al. "Impact of Peritransplant Metronidazole Use on Acute Graft Versus Host Disease in Allogeneic Hematopoietic Transplant Patients." Transplantation and Cellular Therapy , vol.27, no.3, pp.271, 2021

Kircali, E. Et Al. (2021) . "Impact of Peritransplant Metronidazole Use on Acute Graft Versus Host Disease in Allogeneic Hematopoietic Transplant Patients." Transplantation and Cellular Therapy , vol.27, no.3, p.271.

@article{article, author={Ekin Kircali Et Al. }, title={Impact of Peritransplant Metronidazole Use on Acute Graft Versus Host Disease in Allogeneic Hematopoietic Transplant Patients}, journal={Transplantation and Cellular Therapy}, year=2021, pages={271} }